$315 Million is the total value of VESTOR CAPITAL, LLC's 111 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PEP | Pepsico Inc | $8,192,000 | +1.0% | 86,869 | 0.0% | 2.60% | +6.9% | |
WTFC | Wintrust Financial Corp | $1,597,000 | +0.1% | 29,885 | 0.0% | 0.51% | +6.1% | |
BRKA | Berkshire Hathaway Inc A | $976,000 | -4.7% | 5 | 0.0% | 0.31% | +0.6% | |
STT | State Street Corporation | $208,000 | -13.0% | 3,100 | 0.0% | 0.07% | -8.3% | |
WBA | Walgreen Boots Alliance Inc Co | $187,000 | -1.6% | 2,245 | 0.0% | 0.06% | +3.5% | |
VBR | Vanguard Index Fds Small Cap Vetf | $174,000 | -10.3% | 1,798 | 0.0% | 0.06% | -5.2% | |
EEM | Ishares Tr MSCI Emerging Mktsetf | $98,000 | -16.9% | 2,985 | 0.0% | 0.03% | -11.4% | |
OXY | Occidental Petroleum Corp | $99,000 | -15.4% | 1,501 | 0.0% | 0.03% | -11.4% | |
FMBI | First Midwest Bancorp Del Com | $96,000 | -7.7% | 5,500 | 0.0% | 0.03% | 0.0% | |
SRCL | Stericycle Inc | $84,000 | +5.0% | 600 | 0.0% | 0.03% | +12.5% | |
TTHI | Transition Therapeutics Inc Co | $75,000 | -15.7% | 42,600 | 0.0% | 0.02% | -11.1% | |
RDSA | Royal Dutch Shell Plc Sponsore | $71,000 | -17.4% | 1,500 | 0.0% | 0.02% | -11.5% | |
VTI | Vanguard Index Fds Total Stk Metf | $69,000 | -8.0% | 700 | 0.0% | 0.02% | -4.3% | |
IBB | iShares Tr Nasdaq Biotechnologetf | $63,000 | -18.2% | 208 | 0.0% | 0.02% | -13.0% | |
BIDU | Baidu Com Inc Spons ADR Repstg | $60,000 | -31.0% | 438 | 0.0% | 0.02% | -26.9% | |
XEL | Xcel Energy Inc | $60,000 | +11.1% | 1,686 | 0.0% | 0.02% | +18.8% | |
ALL | AllState | $58,000 | -10.8% | 995 | 0.0% | 0.02% | -10.0% | |
KRE | Spdr Ser Tr Kbw Regl Bkg Etfetf | $57,000 | -8.1% | 1,393 | 0.0% | 0.02% | -5.3% | |
IYW | iShares US Technologyetf | $55,000 | -5.2% | 555 | 0.0% | 0.02% | 0.0% | |
MMC | Marsh & McLennan | $47,000 | -7.8% | 900 | 0.0% | 0.02% | 0.0% | |
VIS | Vanguard Industrials ETFetf | $46,000 | -8.0% | 480 | 0.0% | 0.02% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Microsoft | 44 | Q2 2024 | 8.2% |
JP Morgan Chase & Co | 44 | Q2 2024 | 4.4% |
Unitedhealth Group Inc | 44 | Q2 2024 | 6.3% |
Pepsico Inc | 44 | Q2 2024 | 3.0% |
Johnson & Johnson Com | 44 | Q2 2024 | 3.6% |
Norfolk Southern Corp | 44 | Q2 2024 | 3.7% |
US Bancorp New | 44 | Q2 2024 | 3.5% |
Home Depot | 44 | Q2 2024 | 2.3% |
McDonalds Corporation | 44 | Q2 2024 | 2.5% |
Fiserv Inc | 44 | Q2 2024 | 3.7% |
View VESTOR CAPITAL, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-19 |
13F-HR | 2024-07-30 |
13F-HR | 2024-05-14 |
13F-HR/A | 2024-02-14 |
13F-HR | 2024-02-07 |
13F-HR | 2023-11-08 |
13F-HR/A | 2023-08-21 |
13F-HR | 2023-08-09 |
13F-HR/A | 2023-05-10 |
13F-HR/A | 2023-05-09 |
View VESTOR CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.